• Conditions and diseases

  • Blood and immune system •
  • Cancer •
  • Cardiovascular •
  • Central nervous system •
  • Digestive system •
  • Ear and nose •
  • Endocrine, nutritional and metabolic •
  • Eye •
  • Gynaecology, pregnancy and birth •
  • Infectious diseases •
  • Injuries, accidents and wounds •
  • Mental health and behavioural conditions •
  • Mouth and dental •
  • Musculoskeletal •
  • Respiratory •
  • Skin •
  • Urogenital

• Public health

  • Accidents and injuries •
  • Alcohol •
  • Behaviour change •
  • Cancer •
  • Cardiovascular disease •
  • Child health •
  • Child social care •
  • Chronic illness •
  • Diabetes •
  • Drugs •
  • Environmental health •
  • Infectious diseases •
  • Maternal health •
  • Mental health •
  • Non-communicable diseases •
  • Obesity and diet •
  • Occupational health •
  • Older people •
  • Physical activity •
  • Sexual health •
  • Smoking and tobacco •
  • Transport •
  • Vaccine preventable diseases •
  • Working with and involving communities

• Treatments, Procedures and Devices

  • Bones and joint surgery •
  • Cardiovascular surgery •
  • Cardiovascular system drug treatments •
  • Clinical devices •
  • Diagnostic imaging •
  • Diagnostic procedures •
  • Digestive tract and other abdominal organs surgery •
  • Drug treatments •
  • Endocrine system and breast surgery •
  • Eye surgery •
  • Nervous system surgery •
  • Radiotherapy •
  • Screening •
  • Surgical procedures •
  • Therapeutic procedures •
  • Tissue and organ donation •
  • Urogenital surgery

• Guidance by type

  • Clinical Guidelines •
  • Technology appraisals •
  • Public health guidance •
  • Diagnostics guidance •
  • Interventional procedures guidance •
  • Medical technologies guidance •
  • Cancer service guidance •
  • Quality standards

• Guidance by date

  • View the guidance by date published

About NICE guidance Close

Navigation

• NICE guidance

• Find guidance
• NICE Pathways
• Latest guidance
• Guidance by type
• Guidance in development
• How guidance is produced
• NICE guidance research recommendations
• Guidance for patients and public
• Other publications
• Patient safety solutions pilot
• Quality standards

Tuberculosis: interferon gamma tests (update)

Tuberculosis: interferon gamma tests for the diagnosis of latent tuberculosis

Status:	History
Publication date:	March 2011
Wave:	0
Process:	SCG
Topic area: Diagnostic procedures Infectious diseases Respiratory

Project team | Schedule | Project history | Key documents

 

NICE project team

Centre for clinical practice lead:	Phil Alderson
Communications manager:	Phil Ranson
Guidelines commissioning manager:	Rachel Ryle
Guidelines coordinator:	Emma Banks
Patient involvement lead:	Barbara Meredith
Implementation lead:	Stardom Furamera
Lead collaborating centre:	Short Clinical Guidelines Technical Team (SCGTT)
Guidelines Development Group:	The Guideline Development Group (GDG) oversees the development process.

Top

Email enquiries

If you have any queries please email nice@nice.org.uk

Top

 

Provisional schedule

Scoping workshop:	06 November 2009
Consultation on draft scope with stakeholders:	09 December - 11 January 2010
Consultation on draft guideline with stakeholders:	08 July - 05 August 2010
Pre-publication check:	07 December 2010 - 21 December 2010
Publication date:	March 2011

Top

 

Project history

Date   Update   16 February 2011   The pre-publication check is complete.   30 June 2010   The final scope was amended in June 2010. The scope defines what aspects of care are covered by the guideline and to whom it applies. Comments that were made by stakeholders during the consultation on the scope can be seen in the scope consultation table.The Guideline Development Group (GDG) oversees the development process.

Top

 

Key documents

Tuberculosis: interferon gamma tests (update): pre-publication check 07 December 2010 Tuberculosis: interferon gamma tests (update): remit 18 November 2009 Tuberculosis: interferon gamma tests (update): stakeholder lists and how to register 11 January 2010 Tuberculosis: interferon gamma tests (update): scoping workshop, consultation and final scope 09 December 2009 Tuberculosis: interferon gamma tests (update): guideline development and consultation 08 July 2010 Short guideline process 30 December 2009

This page was last updated: 01 April 2011